(a) A retail drug that is marketed or distributed in accordance with an abbreviated new drug application approved under 21 U.S.C. 355(j);
(b) An authorized generic as defined by 42 C.F.R. 447.502; or
(c) A drug that entered the market before 1962 that was not originally marketed under a new drug application.
(2) The status of the generic drug market includes but is not limited to:
(a) The prices of generic drugs on a year-to-year basis;
(b) The degree to which generic drug prices affect insurance premiums;
(c) Annual changes in health insurance cost-sharing for generic drugs;
(d) The potential for and history of generic drug shortages; and
(e) The degree to which generic drug prices affect annual spending in the state medical assistance program. [2021 c.598 §6; 2025 c.166 §4]
MORTGAGE RESCUE FRAUD PREVENTION ACT
(Foreclosure Consultants)